Zenas Biopharma (ZBIO) PT Raised to $55 at Guggenheim
Tweet Send to a Friend
Guggenheim analyst Yatin Suneja raised the price target on Zenas Biopharma (NASDAQ: ZBIO) to $55.00 (from $45.00) while maintaining a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
